规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | NP-G2-044 is a highly potent, orally bioavailable inhibitor of fascin, with an IC50 of approximately 2 μM. It effectively impedes tumor metastasis and enhances the antitumor immune response [1][2]. |
体内研究 | NP-G2-044 (100 mg/kg; i.p.; daily for 18 days) suppresses breast tumor metastasis in mouse models [1]. Following oral administration, NP-G2-044 acts by targeting and binding to fascin, thereby disrupting its interaction with actin filaments. Consequently, it prevents actin bundling and filopodia formation. This interference with actin cytoskeletal reorganization hampers the dynamic changes in cell shape required for tumor cell migration and invasion, ultimately leading to inhibition of tumor cell migration and metastasis [3]. |
体外研究 | NP-G2-044 suppresses the migration of MDA-MB-231 tumor cells with an IC50 of approximately 10 μM. It reduces filopodial formation, consequently leading to decreased lamellipodial formation [1]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.50mL 0.50mL 0.25mL |
12.52mL 2.50mL 1.25mL |
25.04mL 5.01mL 2.50mL |
CAS号 | 1807454-59-6 |
分子式 | C21H16F3N3O2 |
分子量 | 399.37 |
SMILES Code | O=C(NC1=NN(C=2C=CC=CC12)CC3=CC=C(C=C3)C(F)(F)F)C=4C=COC4C |
MDL No. | MFCD32708511 |
别名 | |
运输 | 蓝冰 |
InChI Key | XLLRLAABUFOJPC-UHFFFAOYSA-N |
Pubchem ID | 91844684 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
溶解方案 |
DMSO: 105 mg/mL(262.92 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|